Be among the first to preview our new Workspace Protection features. đź’»
With the DNS Protection for Endpoints, you’ll get secure, private, policy-controlled protection powered by our global network of DNS Protection POPs.
Join the #EarlyAccessProgram: soph.so/1j0fs2
📢[#SEHH2024] – We were honored to see Dr. Jaime Sanz Caballer present promising data on MaaT013 from our Early Access program at the @sehh_es Congress. Based on data from 140 patients treated for acute Graft-versus-Host Disease (#aGvHD), MaaT013 demonstrated a clear reduction in disease burden and improved Overall Survival (OS), with a 12-month survival rate of 42% compared to only 15% in published data (Abedin et al., Br J Haematol, 2021).
Further investigations are currently ongoing in a phase 3 trial for MaaT013 in aGvHD, with patient recruitment now complete. Stay tuned for topline results!
#acuteGvHD#SEHH#SETH#Hematology#Cancer#Microbiome#EarlyAccessProgram#GvHD
For more details, you can access the data presented in April 2024 at the EBMT Annual meeting: maatpharma.com/wp-content/up…
📢[#SEHH2024] - We are proud to announce that Dr. Jaime Sanz Caballer will present promising data from our Early Access program where 140 patients were treated with acute Graft-versus-Host Disease (#aGvHD) with MaaT013, our lead asset currently in a fully recruited Phase 3 trial. These encouraging results provide renewed hope for patients with limited treatment options! The data were also shared earlier this year at the EBMT Annual Meeting in April 2024.
Want to learn more? Join the @sehh_es Congress, October 24-26, at the Palacio de Congresos de Palma!
#acuteGvHD#SEHH#SETH#Hematology#Cancer#Microbiome#EarlyAccessProgram
For more information, visit: hemato2024.com/
An exciting week at #5GHub with the 5G Early Access Program in partnership with @deutschetelekom and @hubraum! Engineers from Forma Vision and @MatsukoCompany are testing DevEdge #5G APIs on a fully functioning 5G standalone network. We can't wait to see things unfold!